Literature DB >> 10939532

Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment.

H Shiiki1, K Dohi.   

Abstract

Primary focal segmental glomerulosclerosis (FSGS) is the representative of refractory nephrotic syndrome in both adults and children. We review the clinical course and predictors of renal outcome in adult FSGS. Patients resistant to treatment frequently develop end-stage renal disease (ESRD), whereas patients achieving a remission show an excellent outcome. The renal survival rate in Japanese patients is 68.7% in 10 years and 31.4% in 20 years, indicating a better prognosis compared with the previous studies. When clinical and histological features at presentation have been evaluated by multivariate analysis, serum creatinine concentrations (>1.5 mg/dl) and the presence of tubulo-interstitial lesions (>20%) are significant positive predictors of progression to ESRD. We also discuss treatment for adult FSGS, with emphasis on intensive and prolonged therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939532     DOI: 10.2169/internalmedicine.39.606

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

Authors:  Dominik G Haider; Salome Masghati; Georg Goliasch; Valentin Fuhrmann; Afschin Soleiman; Michael Wolzt; Andreas Baierl; Wilfred Druml; Walter H Hörl
Journal:  J Nephrol       Date:  2014-03-08       Impact factor: 3.902

2.  Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis.

Authors:  Asiri S Abeyagunawardena; Neil J Sebire; R Anthony Risdon; Michael J Dillon; Lesley Rees; William Van't Hoff; Pallegoda V Kumarasiri; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2006-12-05       Impact factor: 3.714

3.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714

4.  Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Authors:  Yaojun Liang; Yu Jin; Yuning Li
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

5.  Kidney biopsy in patients with glomerulonephritis: is the earlier the better?

Authors:  Dominik G Haider; Alexander Friedl; Slobodan Peric; Günther F Wiesinger; Michael Wolzt; Julian Prosenz; Henrik Fischer; Walter H Hörl; Afschin Soleiman; Valentin Fuhrmann
Journal:  BMC Nephrol       Date:  2012-06-08       Impact factor: 2.388

6.  The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis.

Authors:  A Gheissari; D Taheri; S Mozafarpour; H Beigy; P Samanianpoor; A Merrikhi; Z Farajzadegan
Journal:  Indian J Nephrol       Date:  2012-11

7.  A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.

Authors:  Howard Trachtman; Fernando C Fervenza; Debbie S Gipson; Peter Heering; David R W Jayne; Harm Peters; Stefano Rota; Giuseppe Remuzzi; L Christian Rump; Lorenz K Sellin; Jeremy P W Heaton; James B Streisand; Marjie L Hard; Steven R Ledbetter; Flavio Vincenti
Journal:  Kidney Int       Date:  2011-03-02       Impact factor: 10.612

8.  C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.

Authors:  Kipyo Kim; Hyung-Eun Son; Ji-Young Ryu; Hajeong Lee; Seung Hyeok Han; Dong-Ryeol Ryu; Jin Ho Paik; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin; Se Won Oh
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.